Cargando…

FOXA1 Regulation Turns Benzamide HDACi Treatment Effect-Specific in BC, Promoting NIS Gene-Mediated Targeted Radioiodine Therapy

Human sodium iodide symporter (NIS) gene mediated radio-ablation is a successful procedure in thyroid cancer clinics. In recent years, natural expression of NIS is reported in breast cancer (BC) cases but is yet to make its mark as a therapeutic procedure in BC clinics. A pre-exposure to histone dea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rathod, Maitreyi, Kelkar, Madhura, Valvi, Snehal, Salve, Girish, De, Abhijit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554325/ https://www.ncbi.nlm.nih.gov/pubmed/33102692 http://dx.doi.org/10.1016/j.omto.2020.08.015

Ejemplares similares

In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi)
por: Friedrich, Annabelle, et al.
Publicado: (2020)

Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake
por: Chung, Taemoon, et al.
Publicado: (2015)

Evaluation of Radioiodinated Fluoronicotinamide/Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma
por: Chen, Chao-Cheng, et al.
Publicado: (2020)

Induction of Sodium/Iodide Symporter (NIS) Expression and Radioiodine Uptake in Non-Thyroid Cancer Cells
por: Liu, Zhi, et al.
Publicado: (2012)

Viral Dose, Radioiodine Uptake, and Delayed Efflux in Adenovirus Mediated NIS Radiovirotherapy Correlates with Treatment Efficacy
por: Trujillo, Miguel A., et al.
Publicado: (2012)

HDACIs and the inhibition of invasive potential
por: Dent, Paul
Publicado: (2013)

Sodium Butyrate Enhances the Cytotoxic Effect of Etoposide in HDACi-Sensitive and HDACi-Resistant Transformed Cells
por: Gnedina, Olga O., et al.
Publicado: (2023)

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
por: Suraweera, Amila, et al.
Publicado: (2018)

A Steep Radioiodine Dose Response Scalable to Humans in Sodium Iodide Symporter (NIS) Mediated Radiovirotherapy for Prostate Cancer
por: Trujillo, Miguel A., et al.
Publicado: (2012)

The Role of HDACs and HDACi in Cartilage and Osteoarthritis
por: Zhang, He, et al.
Publicado: (2020)

A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression
por: Warner, Susanne G., et al.
Publicado: (2019)

CLU blocks HDACI-mediated killing of neuroblastoma
por: Subramanian, Chitra, et al.
Publicado: (2010)

Specificity and Application of the Lantibiotic Protease NisP
por: Montalbán-López, Manuel, et al.
Publicado: (2018)

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
por: Ververis, Katherine, et al.
Publicado: (2013)

HDACiDB: a database for histone deacetylase inhibitors
por: Murugan, Kasi, et al.
Publicado: (2015)

Managing NFS and NIS /
por: Stern, Hal
Publicado: (1992)

Managing NFS and NIS
por: Eisler, Mike, et al.
Publicado: (2001)

Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer
por: Chan, Daniel, et al.
Publicado: (2013)

Vimentin, colon cancer progression and resistance to butyrate and other HDACis
por: Lazarova, Darina L., et al.
Publicado: (2016)

The Promising Role of New Generation HDACis in Anti-Cancer Therapies
por: Hervouet, Eric
Publicado: (2018)

Teratoma Growth Retardation by HDACi Treatment of the Tumor Embryonal Source
por: Krasic, Jure, et al.
Publicado: (2020)

HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity?
por: Squarzoni, Angelica, et al.
Publicado: (2022)

Targeting stem cells in the realm of drug-resistant breast cancer
por: Dey, Pranay, et al.
Publicado: (2019)

FOXA1 defines cancer cell specificity
por: Zhang, Gaihua, et al.
Publicado: (2016)

Foxa1 and Foxa2 Are Required for Formation of the Intervertebral Discs
por: Maier, Jennifer A., et al.
Publicado: (2013)

Non-Enzymatic Glucose Detection Based on NiS Nanoclusters@NiS Nanosphere in Human Serum and Urine
por: Arivazhagan, Mani, et al.
Publicado: (2021)

HDACi and Nrf2: not from alpha to omega but from acetylation to OA
por: Jahr, Holger
Publicado: (2015)

Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
por: Bayat Mokhtari, Reza, et al.
Publicado: (2017)

Low-dose HDACi potentiates anti-tumor activity of macrophages in immunotherapy
por: Li, Xiaolei, et al.
Publicado: (2021)

Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression
por: Na, Juri, et al.
Publicado: (2023)

Nicotinamide: a Class III HDACi Delays In Vitro Aging of Mouse Oocytes
por: LEE, Ah Reum, et al.
Publicado: (2013)

PB2396: HDACI COMBINED WITH LB100 PROMOTES THE OCCURRENCE OF FERROZOSIS IN CTCL
por: Shi, Wenyu
Publicado: (2023)

Identification of distinct nisin leader peptide regions that determine interactions with the modification enzymes NisB and NisC()
por: Khusainov, Rustem, et al.
Publicado: (2013)

Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer
por: Zhang, Zongjing, et al.
Publicado: (2014)

Direct solvent free synthesis of bare α-NiS, β-NiS and α-β-NiS composite as excellent electrocatalysts: Effect of self-capping on supercapacitance and overall water splitting activity
por: Shombe, Ginena Bildard, et al.
Publicado: (2020)

Benzamide oxime
por: Xu, Shu-Qing, et al.
Publicado: (2008)

Reduced graphene oxide decorated with octahedral NiS(2)/NiS nanocrystals: facile synthesis and tunable high frequency attenuation
por: Lu, Min, et al.
Publicado: (2019)

Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance
por: Domanskyi, Andrii, et al.
Publicado: (2014)

Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression
por: Thanan, Raynoo, et al.
Publicado: (2020)

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
por: Grassadonia, Antonino, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2iog7vov8l1h559dt67tgbjk4t